Monthly Archives: June 2019

Big Pharma R&D Budgets in 2018

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com         SPECIAL REPORT #24   Big Pharma R&D Budgets in 2018     In January of this year we had indicated that the US FDA had approved 59 NMES (new medical entities) in 2018 topping its previous record of 53 back in […]

read more

US FDA approves Zolgnesma®, the world most expensive drug at $2.1 million

      Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #23   US FDA approves Zolgnesma®, the world most expensive drug at $2.1 million     Last week the US FDA approved Novartis Zolgensma®, a gene therapy for the treatment of patients younger than two years of age who […]

read more